As compared to control organoids, we observed that transcript levels of IL18 were not altered in NASH organoids, which is in line with the results from the pathway analysis that suggest a later dysregulation of IL-18 signaling (Figure 5E). The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.